基于循证的伊布替尼不良反应及药学监护
李雁铭, 赵志刚
Evidence-based ibrutinib-related adverse reactions and pharmaceutical care
LI Yanming, ZHAO Zhigang
中国药物警戒 . 2022, (7): 807 -811 .  DOI: 10.19803/j.1672-8629.2022.07.26